• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险状况与早产儿视网膜病变严重程度和治疗的关联。

Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity.

出版信息

J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec;60(6):e75-e78. doi: 10.3928/01913913-20231026-01. Epub 2023 Nov 1.

DOI:10.3928/01913913-20231026-01
PMID:38019943
Abstract

This study describes retinopathy of prematurity treatment practices using Medicaid and commercial claims databases. Infants with Medicaid tend to be sicker overall and have higher rates of retinopathy of prematurity requiring treatment than those with commercial insurance. Among patients who required treatment, those with Medicaid were more likely to receive anti-vascular endothelial growth factor than laser treatment. .

摘要

这项研究使用医疗补助和商业索赔数据库描述了早产儿视网膜病变的治疗实践。与拥有商业保险的婴儿相比,拥有医疗补助的婴儿总体上往往病情更重,且需要治疗的早产儿视网膜病变发病率更高。在需要治疗的患者中,接受抗血管内皮生长因子治疗的可能性高于激光治疗。

相似文献

1
Association of Health Insurance Status With Severity and Treatment Among Infants With Retinopathy of Prematurity.医疗保险状况与早产儿视网膜病变严重程度和治疗的关联。
J Pediatr Ophthalmol Strabismus. 2023 Nov-Dec;60(6):e75-e78. doi: 10.3928/01913913-20231026-01. Epub 2023 Nov 1.
2
RATES AND RISK FACTORS FOR RECURRENCE OF RETINOPATHY OF PREMATURITY AFTER LASER OR INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR MONOTHERAPY.早产儿视网膜病变激光或玻璃体腔内抗血管内皮生长因子单药治疗后复发的发生率及危险因素。
Retina. 2020 Sep;40(9):1793-1803. doi: 10.1097/IAE.0000000000002663.
3
Increased incidence of retinopathy of prematurity and evolving treatment modalities at a Canadian tertiary centre.加拿大一家三级中心早产儿视网膜病变发病率的增加和不断发展的治疗方式。
Can J Ophthalmol. 2019 Apr;54(2):269-274. doi: 10.1016/j.jcjo.2018.05.005. Epub 2018 Jul 20.
4
Non-invasive Respiratory Support and Severe Retinopathy of Prematurity.无创呼吸支持与重度早产儿视网膜病变
J Pediatr Ophthalmol Strabismus. 2016 Aug 17;53:e47-50. doi: 10.3928/01913913-20160722-03.
5
Retinal Detachment after Treatment of Retinopathy of Prematurity with Laser versus Intravitreal Anti-Vascular Endothelial Growth Factor.早产儿视网膜病变激光治疗与玻璃体内抗血管内皮生长因子治疗后视网膜脱离。
Ophthalmology. 2021 Aug;128(8):1188-1196. doi: 10.1016/j.ophtha.2020.12.028. Epub 2020 Dec 31.
6
Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.玻璃体内注射贝伐单抗治疗 3 期及以上早产儿视网膜病变的疗效。
N Engl J Med. 2011 Feb 17;364(7):603-15. doi: 10.1056/NEJMoa1007374.
7
Comparison of the Efficacy Between Intravitreal Aflibercept and Laser Photocoagulation in the Treatment of Retinopathy of Prematurity.玻璃体内注射阿柏西普与激光光凝治疗早产儿视网膜病变的疗效比较
J Pediatr Ophthalmol Strabismus. 2020 Jan 1;57(1):54-60. doi: 10.3928/01913913-20191104-01.
8
[Epidemiology and treatment of retinopathy of prematurity. The Hannover data in the Retina.net ROP registry from 2001-2017].早产儿视网膜病变的流行病学与治疗。2001年至2017年视网膜网ROP登记处的汉诺威数据
Ophthalmologe. 2022 May;119(5):497-505. doi: 10.1007/s00347-021-01528-9. Epub 2021 Nov 22.
9
Favorable outcomes in the treatment of aggressive posterior retinopathy of prematurity.早产儿后部进展性视网膜病变治疗效果良好。
Eur J Ophthalmol. 2021 Jan;31(1):179-183. doi: 10.1177/1120672119886989. Epub 2019 Nov 13.
10
An Observational Study of Different Treatment Practices for Aggressive Posterior Retinopathy of Prematurity.一项关于侵袭性早产儿视网膜病变不同治疗方法的观察性研究。
J Pediatr Ophthalmol Strabismus. 2021 Nov-Dec;58(6):370-376. doi: 10.3928/01913913-20210423-01. Epub 2021 Jul 6.

引用本文的文献

1
Association of Childhood Neighborhood Opportunity With Retinopathy of Prematurity.儿童社区机会与早产儿视网膜病变的关联
Am J Ophthalmol. 2025 Jul 16;279:86-90. doi: 10.1016/j.ajo.2025.07.010.